32849187|t|Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis.
32849187|a|Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative condition characterized by the progressive loss of motor neurons. Patients usually die 3-5 years after diagnosis from respiratory failure. Several studies investigated the role of vitamin D as a biomarker or a therapeutic option for ALS patients. To clarify the scientific evidence, we performed a systematic review and different meta-analyses regarding the potential role of vitamin D in ALS. Methods: We performed a systematic review of clinical trials, cohorts, and case-control studies retrieved from PubMed, EMBASE, and Cochrane databases reporting vitamin D levels as a putative biomarker for ALS diagnosis or prognosis or the effect of vitamin D supplementation in ALS patients. Whenever possible, data were pooled using a random-effects model, with an assessment of heterogeneity. Results: Out of 2,996 articles retrieved, we finally included 13 research articles, 12 observational studies (50% prospective), and 1 clinical trial. We found that ALS patients had slightly lower levels of vitamin D than controls (mean difference -6 ng/ml, 95% CI [-10.8; -1.3]), but important confounding factors were not considered in the studies analyzed. We found no relationship between vitamin D levels and ALS functional rate score-revised (ALSFRS-R), with highly heterogeneous results. Discordant results were reported in three studies regarding survival. Finally, five studies reported the effects of vitamin D supplementation with discordant results. Two of them showed a small improvement, whereas two others showed a deleterious effect on ALSFRS-R. One very small clinical trial with important methodological limitations showed some improvement in ALSFRS-R with high doses of vitamin D compared with normal doses. Conclusions: Our review did not find evidence to support the role of vitamin D on ALS diagnosis, prognosis, or treatment. Most studies had important limitations, mostly regarding the risk of bias for not considering confounding factors. Vitamin D supplementation should be offered to ALS patients to avoid other health issues related to vitamin D deficiency, but there is not enough evidence to support the use of vitamin D as a therapy for ALS.
32849187	20	29	Vitamin D	Chemical	MESH:D014807
32849187	33	62	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
32849187	115	144	Amyotrophic lateral sclerosis	Disease	MESH:D000690
32849187	146	149	ALS	Disease	MESH:D000690
32849187	156	183	neurodegenerative condition	Disease	MESH:D019636
32849187	240	248	Patients	Species	9606
32849187	257	260	die	Disease	
32849187	292	311	respiratory failure	Disease	MESH:D012131
32849187	354	363	vitamin D	Chemical	MESH:D014807
32849187	407	410	ALS	Disease	MESH:D000690
32849187	411	419	patients	Species	9606
32849187	550	559	vitamin D	Chemical	MESH:D014807
32849187	563	566	ALS	Disease	MESH:D000690
32849187	728	737	vitamin D	Chemical	MESH:D014807
32849187	773	776	ALS	Disease	MESH:D000690
32849187	817	826	vitamin D	Chemical	MESH:D014807
32849187	846	849	ALS	Disease	MESH:D000690
32849187	850	858	patients	Species	9606
32849187	1127	1130	ALS	Disease	MESH:D000690
32849187	1131	1139	patients	Species	9606
32849187	1169	1178	vitamin D	Chemical	MESH:D014807
32849187	1355	1364	vitamin D	Chemical	MESH:D014807
32849187	1376	1379	ALS	Disease	MESH:D000690
32849187	1573	1582	vitamin D	Chemical	MESH:D014807
32849187	1851	1860	vitamin D	Chemical	MESH:D014807
32849187	1958	1967	vitamin D	Chemical	MESH:D014807
32849187	1971	1974	ALS	Disease	MESH:D000690
32849187	2126	2135	Vitamin D	Chemical	MESH:D014807
32849187	2173	2176	ALS	Disease	MESH:D000690
32849187	2177	2185	patients	Species	9606
32849187	2303	2312	vitamin D	Chemical	MESH:D014807
32849187	2330	2333	ALS	Disease	MESH:D000690
32849187	Negative_Correlation	MESH:D014807	MESH:D000690

